PERRIGO CO PLC

PRGO represents Perrigo Company plc, a global healthcare company that develops, manufactures, and supplies over-the-counter consumer healthcare products and generic prescription medicines. The company operates in segments such as Consumer Self-Care Americas, Consumer Self-Care International, and Prescription Pharmaceuticals. Perrigo is headquartered in Ireland and has a long history in store-brand health products.

The 52-week range shows the lowest and highest prices at which PRGO traded over the past year. It helps investors gauge recent price volatility and where the current price sits relative to that span. For the latest 52-week high and low, check the current quote and key statistics displayed on this PRGO stock page.

Start by comparing PRGO's valuation multiples, such as price-to-earnings, price-to-sales, and enterprise value-to-EBITDA, with those of peers in the consumer healthcare and generic pharmaceuticals sectors. Also review growth trends, margins, and debt levels, since Perrigo's mix of store-brand and prescription products can affect how the market values it relative to branded competitors.

PRGO can trade in pre-market and after-hours sessions on U.S. exchanges, though volume is often thinner and spreads wider than during regular hours. Extended-hours trading requires a broker that supports it. Prices can move on news released outside regular sessions, so confirm the latest quote and session details on this PRGO page before placing orders.

Review PRGO's quarterly and annual reports, focusing on revenue growth, gross and operating margins, EPS, and cash flow. Compare results year over year and against management guidance. Segment performance matters because Perrigo reports consumer self-care and prescription businesses separately. These statements and metrics are available in the company's SEC filings and on this PRGO page.

Key risks include pricing pressure in generic pharmaceuticals, intense competition in store-brand consumer health, regulatory and product-liability exposure, and integration or restructuring challenges. Currency swings and input-cost inflation can also affect results. Because Perrigo operates globally, changes in healthcare policy and consumer demand may weigh on performance. Review the risk factors in PRGO's latest annual report for specifics.